The Bull Market In Orion Energy Systems, Inc (OESX) And Dova Pharmaceuticals, Inc. (DOVA) Isn’t Dead Yet

The price of Orion Energy Systems, Inc (NASDAQ:OESX) went up by $0.03 now trading at $1.5. Their shares witnessed a 183.02% increase from the 52-week low price of $0.53 they recorded on 2018-12-24. Even though it is still -12.67% behind the $1.69 high touched on 2019-05-01. The last few days have been rough for the stock, as its price has decreased by -8.54% during the week. It has also performed better over the past three months, as it added around 61.38% while it has so far climbed around 87.5% during the course of a year. The stock of OESX recorded 162.7% uptrend from the beginning of this year till date. The 12-month potential price target for Orion Energy Systems, Inc is set at $2.42. This target means that the stock has an upside potential to increase by 61.33% from the current trading price.

4 institutions entered new Orion Energy Systems, Inc (NASDAQ:OESX) positions, 9 added to their existing positions in these shares, 12 lowered their positions, and 5 exited their positions entirely.

Orion Energy Systems, Inc (OESX) trade volume has decreased by -67.68% as around 103,853 shares were sold when compared with its 50-day average volume of traded shares which is 321,304. At the moment, OESX is witnessing a downtrend, as it is trading -6.48% below its 20-day SMA, 14.87% above its 50-day SMA, and 50.09% above its 200-day SMA. The company runs an ROE of roughly -35.1%, with financial analysts predicting that their earnings per share growth will be around 25% per annum for the next five year. This will be compared to the 1.6% increase witnessed over the past five years.

The first technical resistance point for Orion Energy Systems, Inc (NASDAQ:OESX) will likely come at $1.58, marking a 5.06% premium to the current level. The second resistance point is at $1.66, about 9.64% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $1.32, the lower end of the range. OESX’s 14-day MACD is -0.08 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 48.65, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 34.73 percent, which is low when compared to that of the 50-day’s 71.43 percent.

The shares of Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) has increased by 4.72%, and now trading at $11.53 on the Wall Street in the intra-day deal, with their shares traded now around 274,735. This is a rise of 120,697 shares over the average 154,038 shares that were traded daily over the last three months. The stock that is trading at $11.53 went higher by 105.16% from its 52-week low of $5.62 that it attained back on 2018-12-20. The stock recorded a 52-week high of $35.33 nearly 324 days ago on 2018-06-26.

DOVA stock has performed well over the past 30 days, as it added 36.13% while its price climbed by 52.11% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 14.96% over the last week. The stock’s 12-month potential target price is now at $20.25. This means that the stock price might likely increase by 75.63% from its current trading price. 3 out of 6 Wall Street analysts which represents 50% rated the stock as a buy while the remaining 33.33% rated it as a hold, with 16.67% of analysts rating it as a sell.

Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) has been utilizing an ROE that is roughly -87.2%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the 0% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 21.61% above its 20-day SMA, 27.89% above its 50-day SMA, and -19.02% below its 200-day SMA. In percentage terms, the aggregate Dova Pharmaceuticals, Inc. shares held by institutional investors is 41.7%. 13 institutions jumped in to acquire Dova Pharmaceuticals, Inc. (DOVA) fresh stake, 23 added to their current holdings in these shares, 34 lowered their positions, and 10 left no stake in the company.

The stock’s 9-day MACD is 0.66 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 78.14, which shows that its stock has been overbought. The 20-day historical volatility for the shares stand at 60.03 percent, which is less when compared to that of the 50-day’s 62.78 percent. On the daily chart, we see that the stock could reach the first level of resistance at $12.15, sporting a 5.1% premium to the current level. The next resistance point is at $12.78, representing nearly 9.78% premium to the current market price of Dova Pharmaceuticals, Inc. (DOVA). On the other hand, failure to breach the immediate hurdles can drag it down to $10.38, the lower end of the range.